ProMIS Neurosciences, Inc. (PMN)

NCM – Цена в реальном времени. Валюта: USD

14.71

-0.26 (-1.74%)

Рынок открыт: Aug 12, 2026, 12:40 PM EDT

14.41

-0.56 (-3.74%)

Предыдущая сессия: Aug 11, 2026, 5:12 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

03.08.2026

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the second quarter ended June 30, 2026, and provide corporate updates on August 13, 2026.

Видео

No Data

There is no data to display

ProMIS Neurosciences, Inc. (PMN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Видео

No Data

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Видео

No Data

Search stocks

ProMIS Neurosciences, Inc. (PMN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Видео

No Data

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

Видео

No Data